|
|
| CP2D6_HUMAN |
CYP2D6 |
Cytochrome P450 2D6 |
5.433e-22 |
1.00
|
| DRD3_HUMAN |
DRD3 |
D(3) dopamine receptor |
2.283e-11 |
1.00
|
| ACM1_HUMAN |
CHRM1 |
Muscarinic acetylcholine receptor M1 |
3.564e-11 |
1.00
|
| HRH1_HUMAN |
HRH1 |
Histamine H1 receptor |
8.317e-11 |
1.00
|
| ADA1B_RAT |
Adra1b |
Alpha-1B adrenergic receptor |
3.882e-10 |
1.00
|
| SC6A3_HUMAN |
SLC6A3 |
Sodium-dependent dopamine transporter |
9.825e-10 |
1.00
|
| ADA2A_HUMAN |
ADRA2A |
Alpha-2A adrenergic receptor |
4.108e-08 |
1.00
|
| ACM5_HUMAN |
CHRM5 |
Muscarinic acetylcholine receptor M5 |
7.158e-08 |
1.00
|
| 5HT2B_HUMAN |
HTR2B |
5-hydroxytryptamine receptor 2B |
8.476e-08 |
1.00
|
| ACM4_HUMAN |
CHRM4 |
Muscarinic acetylcholine receptor M4 |
1.583e-07 |
1.00
|
| ACM2_HUMAN |
CHRM2 |
Muscarinic acetylcholine receptor M2 |
2.401e-06 |
1.00
|
| 5HT2A_HUMAN |
HTR2A |
5-hydroxytryptamine receptor 2A |
4.641e-06 |
1.00
|
| ACM3_HUMAN |
CHRM3 |
Muscarinic acetylcholine receptor M3 |
0.0001672 |
1.00
|
| 5HT2C_HUMAN |
HTR2C |
5-hydroxytryptamine receptor 2C |
0.0002304 |
1.00
|
| ADA1D_HUMAN |
ADRA1D |
Alpha-1D adrenergic receptor |
0.0004394 |
1.00
|
| CAC1B_RAT |
Cacna1b |
Voltage-dependent N-type calcium channel subunit alpha-1B |
1.812e-118 |
0.61
|
| CACB1_RAT |
Cacnb1 |
Voltage-dependent L-type calcium channel subunit beta-1 |
1.437e-95 |
0.61
|
| CA2D2_RAT |
Cacna2d2 |
Voltage-dependent calcium channel subunit alpha-2/delta-2 |
2.641e-91 |
0.43
|
| CACB1_HUMAN |
CACNB1 |
Voltage-dependent L-type calcium channel subunit beta-1 |
2.641e-91 |
0.43
|
| CAC1A_HUMAN |
CACNA1A |
Voltage-dependent P/Q-type calcium channel subunit alpha-1A |
1.271e-82 |
0.43
|
| CA2D1_RAT |
Cacna2d1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 |
2.151e-66 |
0.61
|
| NMUR1_HUMAN |
NMUR1 |
Neuromedin-U receptor 1 |
7.955e-55 |
0.44
|
| OPRX_HUMAN |
OPRL1 |
Nociceptin receptor |
1.507e-52 |
0.53
|
| NMUR2_HUMAN |
NMUR2 |
Neuromedin-U receptor 2 |
8.161e-51 |
0.44
|
| TYRP1_MOUSE |
Tyrp1 |
5,6-dihydroxyindole-2-carboxylic acid oxidase |
1.654e-40 |
0.34
|
| OPRD_HUMAN |
OPRD1 |
Delta-type opioid receptor |
3.981e-25 |
0.59
|
| BLAB_BACCE |
|
Metallo-beta-lactamase type 2 |
4.642e-25 |
0.28
|
| HRH4_HUMAN |
HRH4 |
Histamine H4 receptor |
6.793e-25 |
0.35
|
| DRD5_HUMAN |
DRD5 |
D(1B) dopamine receptor |
4.101e-23 |
0.39
|
| OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
6.295e-23 |
0.53
|
| 5HT3B_RAT |
Htr3b |
5-hydroxytryptamine receptor 3B |
1.274e-21 |
0.37
|
| OPRK_HUMAN |
OPRK1 |
Kappa-type opioid receptor |
1.314e-21 |
0.59
|
| CAC1G_HUMAN |
CACNA1G |
Voltage-dependent T-type calcium channel subunit alpha-1G |
2.202e-20 |
0.43
|
| SETD7_HUMAN |
SETD7 |
Histone-lysine N-methyltransferase SETD7 |
4.408e-19 |
0.32
|
| 5HT3A_RAT |
Htr3a |
5-hydroxytryptamine receptor 3A |
1.716e-18 |
0.37
|
| SC6A3_RAT |
Slc6a3 |
Sodium-dependent dopamine transporter |
1.991e-18 |
0.46
|
| 5HT3B_HUMAN |
HTR3B |
5-hydroxytryptamine receptor 3B |
1.882e-17 |
0.33
|
| 5HT2A_RAT |
Htr2a |
5-hydroxytryptamine receptor 2A |
1.11e-16 |
0.41
|
| MC4R_HUMAN |
MC4R |
Melanocortin receptor 4 |
1.11e-16 |
0.68
|
| MGLL_MOUSE |
Mgll |
Monoglyceride lipase |
2.22e-16 |
0.43
|
| Q8HY88_BOVIN |
KCNK2 |
Potassium channel subfamily K member 2 |
6.661e-16 |
0.40
|
| SCN2A_RAT |
Scn2a |
Sodium channel protein type 2 subunit alpha |
5.662e-15 |
0.40
|
| PPAP_HUMAN |
ACP3 |
Prostatic acid phosphatase |
1.754e-14 |
0.28
|
| HRH1_CAVPO |
HRH1 |
Histamine H1 receptor |
5.285e-14 |
0.41
|
| MGLL_RAT |
Mgll |
Monoglyceride lipase |
2.255e-13 |
0.43
|
| 5HT2C_RAT |
Htr2c |
5-hydroxytryptamine receptor 2C |
4.756e-13 |
0.41
|
| CALM_BOVIN |
CALM |
Calmodulin |
1.167e-12 |
0.34
|
| 5HT3A_HUMAN |
HTR3A |
5-hydroxytryptamine receptor 3A |
4.101e-12 |
0.36
|
| CA2D1_HUMAN |
CACNA2D1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 |
4.367e-12 |
0.43
|
| VMAT2_RAT |
Slc18a2 |
Synaptic vesicular amine transporter |
1.638e-11 |
0.31
|
| DRD1_HUMAN |
DRD1 |
D(1A) dopamine receptor |
1.772e-11 |
0.40
|
| HRH4_RAT |
Hrh4 |
Histamine H4 receptor |
1.792e-11 |
0.33
|
| SC6A2_HUMAN |
SLC6A2 |
Sodium-dependent noradrenaline transporter |
1.003e-10 |
0.49
|
| ACM1_RAT |
Chrm1 |
Muscarinic acetylcholine receptor M1 |
1.994e-10 |
0.33
|
| MGLL_HUMAN |
MGLL |
Monoglyceride lipase |
2.804e-10 |
0.43
|
| LUXR_ALIFS |
luxR |
Transcriptional activator protein LuxR |
4.291e-10 |
0.29
|
| RCE1_YEAST |
RCE1 |
CAAX prenyl protease 2 |
4.894e-10 |
0.41
|
| ACH10_RAT |
Chrna10 |
Neuronal acetylcholine receptor subunit alpha-10 |
6.024e-10 |
0.31
|
| SC6A4_RAT |
Slc6a4 |
Sodium-dependent serotonin transporter |
8.127e-10 |
0.37
|
| DRD2_HUMAN |
DRD2 |
D(2) dopamine receptor |
1.234e-09 |
0.49
|
| CP19A_RAT |
Cyp19a1 |
Aromatase |
1.64e-09 |
0.37
|
| 5HT2C_MOUSE |
Htr2c |
5-hydroxytryptamine receptor 2C |
1.983e-09 |
0.32
|
| INHA_MYCTU |
inhA |
Enoyl-[acyl-carrier-protein] reductase [NADH] |
2.239e-09 |
0.50
|
| ADA2C_HUMAN |
ADRA2C |
Alpha-2C adrenergic receptor |
2.636e-09 |
0.49
|
| Q8VH27_CAVPO |
GPM2 |
Muscarinic acetylcholine receptor |
3.402e-09 |
0.28
|
| O31048_PORGN |
DPP IV |
Dipeptidyl peptidase IV |
4.869e-09 |
0.37
|
| SGMR1_HUMAN |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
6.464e-09 |
0.49
|
| 5HT2A_PIG |
HTR2A |
5-hydroxytryptamine receptor 2A |
8.61e-09 |
0.39
|
| 5HT1A_RAT |
Htr1a |
5-hydroxytryptamine receptor 1A |
8.683e-09 |
0.49
|
| DRD4_HUMAN |
DRD4 |
D(4) dopamine receptor |
1.077e-08 |
0.40
|
| SC6A4_HUMAN |
SLC6A4 |
Sodium-dependent serotonin transporter |
2.145e-08 |
0.49
|
| AOFA_RAT |
Maoa |
Amine oxidase [flavin-containing] A |
5.805e-08 |
0.47
|
| DRD1_RAT |
Drd1 |
D(1A) dopamine receptor |
5.906e-08 |
0.35
|
| ADA2B_HUMAN |
ADRA2B |
Alpha-2B adrenergic receptor |
7.691e-08 |
0.49
|
| CHKA_HUMAN |
CHKA |
Choline kinase alpha |
7.832e-08 |
0.35
|
| ACM2_RAT |
Chrm2 |
Muscarinic acetylcholine receptor M2 |
8.058e-08 |
0.33
|
| VMAT2_HUMAN |
SLC18A2 |
Synaptic vesicular amine transporter |
1.266e-07 |
0.28
|
| CCR5_HUMAN |
CCR5 |
C-C chemokine receptor type 5 |
2.077e-07 |
0.34
|
| Q8VH26_CAVPO |
GPM3 |
Muscarinic acetylcholine receptor |
2.43e-07 |
0.41
|
| HCN1_HUMAN |
HCN1 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 |
7.169e-07 |
0.35
|
| SCN4A_HUMAN |
SCN4A |
Sodium channel protein type 4 subunit alpha |
1.324e-06 |
0.28
|
| ACHP_LYMST |
|
Acetylcholine-binding protein |
1.569e-06 |
0.38
|
| PRIO_SHEEP |
PRNP |
Major prion protein |
1.657e-06 |
0.30
|
| B2LA1_MOUSE |
Bcl2a1 |
Bcl-2-related protein A1 |
2.475e-06 |
0.30
|
| B2LA1_HUMAN |
BCL2A1 |
Bcl-2-related protein A1 |
3.57e-06 |
0.29
|
| CP51A_HUMAN |
CYP51A1 |
Lanosterol 14-alpha demethylase |
3.933e-06 |
0.30
|
| CAC1C_RAT |
Cacna1c |
Voltage-dependent L-type calcium channel subunit alpha-1C |
4.043e-06 |
0.32
|
| ADA2A_BOVIN |
ADRA2A |
Alpha-2A adrenergic receptor |
4.46e-06 |
0.32
|
| SC6A4_MOUSE |
Slc6a4 |
Sodium-dependent serotonin transporter |
4.778e-06 |
0.32
|
| MBTD1_HUMAN |
MBTD1 |
MBT domain-containing protein 1 |
5.252e-06 |
0.28
|
| PTN22_HUMAN |
PTPN22 |
Tyrosine-protein phosphatase non-receptor type 22 |
5.937e-06 |
0.30
|
| CAC1C_CAVPO |
CACNA1C |
Voltage-dependent L-type calcium channel subunit alpha-1C |
6.032e-06 |
0.36
|
| BLA2_BACCE |
blm |
Metallo-beta-lactamase type 2 |
8.558e-06 |
0.28
|
| CNR1_HUMAN |
CNR1 |
Cannabinoid receptor 1 |
8.841e-06 |
0.49
|